Viewing Study NCT01660360


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2025-12-27 @ 11:13 PM
Study NCT ID: NCT01660360
Status: COMPLETED
Last Update Posted: 2014-01-29
First Post: 2012-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer
Sponsor: PharmAbcine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module